Hematologic Malignancies Testing Industry Supply Chain Anaysis, Growth Opportunities, Top Companies, Revenue Growth and Business Development Report by 2027
According to the
current analysis by Emergen Research, the Global Hematologic Malignancies Testing Market size
is expected to reach USD 5.45 Billion in terms of revenue from USD 1.95 Billion
in 2019, delivering a CAGR of 14.6% through 2027.
The market growth
is driven by the growing prevalence of
multiple myeloma and Leukemia, along with increasing patient awareness
regarding benefits of early diagnosis of diseases
To get leading
market solutions, visit the link below:
https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
Hematologic
malignancies testing can be used to identify and diagnose disorders,
classifying those with the help of hereditary variance instead of symptoms. The
procedure enables more precise diagnosis and efficient therapies, thereby strengthening
patients’ prognosis.
A
SWOT analysis is performed on the leading companies engaged in the Hematologic
Malignancies Testing market to offer a better understanding of the strengths,
opportunities, weaknesses, and threats of the leading companies. It also covers
production and consumption rate, the volatility of prices and demands, market
share, market size, global position, and market position of each player
Key
players in the global hematologic malignancies testing market are ArcherDx,
Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Invitae Corporation,
Abbott Laboratories, NeoGenomics Laboratories, Inc., Cancer Genetics Inc.,
Asuragen, Inc., Invivoscribe, Inc., and Adaptive Biotechnologies Corporation,
among others.
Key
Highlights From Report
In March 2020, Sysmex
Corporation, a leading diagnostic solutions company, received Japan marketing
clearance for the world's largest genome research organization, BGI Group’s coronavirus
kit distribution. This initiative strengthened the company’s position in
Japan.
Emergen Research
has segmented the Global Hematologic Malignancies Testing Market on the basis
of product, technology, disease, end-use, and region:
·
Regional Outlook (Revenue, USD Billion; 2017-2027)
o
North America
1.
U.S.
2.
Canada
3.
Mexico
o
Europe
1.
Germany
2.
U.K.
3.
France
4.
BENELUX
5.
Rest of Europe
o
Asia Pacific
1.
China
2.
Japan
3.
South Korea
4.
India
5.
Rest of APAC
o
Latin America
1.
Brazil
2.
Rest of LATAM
o
Middle East & Africa
1.
Saudi Arabia
2.
U.A.E.
3.
Rest of MEA
Contact Us:
Corporate Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Comments
Post a Comment